Apogee Therapeutics (APGE) Stock Price, Quote, News & History

Comments

Apogee Therapeutics Inc (APGE) Stock Price, Quote, News & History

APGENASDAQ

Trade with Public

$84.01

-0.33-0.39%

At close: Apr 2, 5:00 PM EST

$84.01

-0.33-0.39%

Pre-Market: 4:09 AM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$84.01

Volume / Avg.

0 / 1.08M

Day Range

- - -

52 Wk Range

26.20 - 85.94

Market Cap

$6.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

20.15%

Days to Cover

9.96

Recent Apogee Therapeutics Inc News

Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout

Apogee Therapeutics stock jumps on 52-week eczema data; durable response supports Phase 3 plans later in 2026.

Vandana Singh

One Shot, Six Months of Asthma Relief? Apogee Drug Shows Strong, Long-Lasting Effect In Trial

Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up to 32 weeks and was well-tolerated in patients.

Vandana Singh

Top 2 Health Care Stocks That May Plunge This Month

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-227.45M

Investing Cash Flow (TTM)

-179.57M

Financing Cash Flow (TTM)

396.49M

Free Cash Flow (TTM)

-232.60M

Capital Expenditure (TTM)

-5.15M

Net Change in Cash (TTM)

-10.53M

Analyst Trends and Forecast

2

Oct 25

2

Nov 25

2

Dec 25

2

Jan

7

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.55B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.93

Earnings Yield % (TTM)

-5.02%

Earnings Yield % (FWD)

-5.61%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.12

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$131.55M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$84.01

Volume / Avg.

0 / 1.08M

Day Range

- - -

52 Wk Range

26.20 - 85.94

Market Cap

$6.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

20.15%

Days to Cover

9.96

About

Sector

Health Care

Industry

Biotechnology

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Apogee Therapeutics (APGE) stock?

A

You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Apogee Therapeutics (APGE) competitors?

A

Other companies in Apogee Therapeutics’s space includes: Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Alkermes PLC (NASDAQ:ALKS) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).

Q

What is the forecast, or price target, for Apogee Therapeutics (APGE) stock?

A

Apogee Therapeutics has a consensus price target of $104.40.

Q

What is the current price for Apogee Therapeutics (APGE)?

A

The stock price for Apogee Therapeutics (NASDAQ: APGE) is $84.01 last updated April 6, 2026 at 4:00 PM EDT.

Q

Does Apogee Therapeutics (APGE) pay a dividend?

A

There are no upcoming dividends for Apogee Therapeutics.

Q

When is Apogee Therapeutics (NASDAQ:APGE) reporting earnings?

A

Apogee Therapeutics does not have any upcoming earnings scheduled.

Q

Is Apogee Therapeutics (APGE) going to split?

A

There is no upcoming split for Apogee Therapeutics.

Q

What sector and industry does Apogee Therapeutics (APGE) operate in?

A

Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Cogent Biosciences Inc

Centessa Pharmaceuticals PLC

Xenon Pharmaceuticals Inc

Protagonist Therapeutics Inc

Key Statistics

Open

-

Close

$84.01

Volume / Avg.

0 / 1.08M

Day Range

- - -

52 Wk Range

26.20 - 85.94

Market Cap

$6.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

20.15%

Days to Cover

9.96

Recent Apogee Therapeutics Inc News

Apogee Therapeutics Stock Rallies On Encouraging Eczema Drug Data Readout

Apogee Therapeutics stock jumps on 52-week eczema data; durable response supports Phase 3 plans later in 2026.

Vandana Singh

One Shot, Six Months of Asthma Relief? Apogee Drug Shows Strong, Long-Lasting Effect In Trial

Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up to 32 weeks and was well-tolerated in patients.

Vandana Singh

Top 2 Health Care Stocks That May Plunge This Month

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-227.45M

Investing Cash Flow (TTM)

-179.57M

Financing Cash Flow (TTM)

396.49M

Free Cash Flow (TTM)

-232.60M

Capital Expenditure (TTM)

-5.15M

Net Change in Cash (TTM)

-10.53M

Analyst Trends and Forecast

2

Oct 25

2

Nov 25

2

Dec 25

2

Jan

7

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.55B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

6.93

Earnings Yield % (TTM)

-5.02%

Earnings Yield % (FWD)

-5.61%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.12

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$131.55M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$84.01

Volume / Avg.

0 / 1.08M

Day Range

- - -

52 Wk Range

26.20 - 85.94

Market Cap

$6.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

20.15%

Days to Cover

9.96

About

Sector

Health Care

Industry

Biotechnology

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry